You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港府:已增購約60萬劑科興疫苗
阿思達克 05-05 18:07
政府今日(5日)公佈,已增購約60萬劑克爾來福(科興)疫苗,以應付市民對接種新冠疫苗的需求,該批疫苗今日由北京運抵香港。連同早前的批次,政府至今已合共採購約910萬劑克爾來福疫苗。 發言人表示,新一批克爾來福疫苗抵港後,工作人員隨即按既定程序,對有關疫苗進行檢查及覈對,以確保疫苗符合產品規格及相關的冷鏈運輸標準。 發言人表示,雖然近日疫情稍爲緩和,但Omicron變異病毒株傳播力極高,市民仍須保持警惕。在第五波疫情中,兒童和長者均錄得死亡和重症個案,他們是疫苗接種的重點保護對象。接種疫苗對於預防2019冠狀病毒病感染者出現重症或死亡高度有效。(ca/a) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account